Cochlear Historical Balance Sheet

COH Stock

271.38 1.36 0.50%

Trend analysis of Cochlear balance sheet accounts such as Short Long Term Debt Total of 165.5 M, Other Current Liabilities of 244.4 M or Total Current Liabilities of 762.5 M provides information on Cochlear's total assets, liabilities, and equity, which is the actual value of Cochlear to its prevalent stockholders. By breaking down trends over time using Cochlear balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Cochlear latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cochlear is a good buy for the upcoming year.

Cochlear Inventory

472.86 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cochlear. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Cochlear Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Cochlear at a specified time, usually calculated after every quarter, six months, or one year. Cochlear Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cochlear and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cochlear currently owns. An asset can also be divided into two categories, current and non-current.

Cochlear Balance Sheet Chart

At this time, Cochlear's Cash is comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 1.6 B in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 62 M in 2025.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Liabilities And Stockholders Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Cochlear assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cochlear books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Cochlear balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Cochlear are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Liabilities And Stockholders Equity

The total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation.

Most accounts from Cochlear's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Cochlear current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cochlear. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	201.8M	243.7M	280.3M	165.5M
Total Assets	2.6B	2.7B	3.2B	3.3B

Short Long Term Debt Total Total Assets

Cochlear balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock
Total Assets		0.49	0.93	0.93	0.99	0.99	0.96	-0.72	0.73	0.95	0.95	1.0	0.02	0.9	0.9	0.97	0.85	0.84	0.93	0.83	-0.28	0.94	0.97	1.0	0.28	0.97
Short Long Term Debt Total	0.49		0.44	0.65	0.39	0.44	0.34	0.05	-0.07	0.23	0.49	0.44	-0.44	0.69	0.26	0.48	0.32	0.66	0.28	0.13	-0.64	0.7	0.29	0.53	0.85	0.5
Other Current Liab	0.93	0.44		0.95	0.91	0.92	0.95	-0.57	0.77	0.93	0.82	0.92	0.21	0.79	0.93	0.87	0.79	0.72	0.95	0.79	-0.08	0.92	0.89	0.94	0.31	0.86
Total Current Liabilities	0.93	0.65	0.95		0.88	0.9	0.89	-0.5	0.61	0.85	0.85	0.9	0.06	0.88	0.84	0.88	0.72	0.73	0.86	0.69	-0.27	0.97	0.84	0.94	0.56	0.87
Total Stockholder Equity	0.99	0.39	0.91	0.88		0.99	0.96	-0.81	0.74	0.96	0.96	1.0	0.05	0.88	0.88	0.98	0.86	0.8	0.93	0.84	-0.25	0.88	0.99	0.98	0.18	0.97
Property Plant And Equipment Net	0.99	0.44	0.92	0.9	0.99		0.95	-0.77	0.71	0.94	0.96	0.99	0.07	0.91	0.87	0.99	0.84	0.81	0.93	0.81	-0.27	0.9	0.98	0.99	0.25	0.98
Current Deferred Revenue	0.96	0.34	0.95	0.89	0.96	0.95		-0.7	0.85	0.98	0.86	0.96	0.19	0.78	0.95	0.9	0.83	0.76	0.98	0.89	-0.06	0.89	0.95	0.95	0.13	0.89
Net Debt	-0.72	0.05	-0.57	-0.5	-0.81	-0.77	-0.7		-0.57	-0.75	-0.82	-0.77	-0.03	-0.64	-0.59	-0.8	-0.74	-0.46	-0.65	-0.65	0.11	-0.44	-0.84	-0.7	0.18	-0.8
Retained Earnings	0.73	-0.07	0.77	0.61	0.74	0.71	0.85	-0.57		0.9	0.54	0.74	0.4	0.37	0.92	0.6	0.72	0.48	0.88	0.89	0.29	0.63	0.76	0.69	-0.28	0.57
Accounts Payable	0.95	0.23	0.93	0.85	0.96	0.94	0.98	-0.75	0.9		0.84	0.95	0.24	0.73	0.97	0.88	0.85	0.7	0.99	0.91	-0.01	0.84	0.96	0.93	0.03	0.87
Cash	0.95	0.49	0.82	0.85	0.96	0.96	0.86	-0.82	0.54	0.84		0.96	-0.12	0.96	0.74	0.99	0.81	0.8	0.81	0.7	-0.41	0.84	0.94	0.95	0.32	1.0
Non Current Assets Total	1.0	0.44	0.92	0.9	1.0	0.99	0.96	-0.77	0.74	0.95	0.96		0.04	0.89	0.88	0.98	0.86	0.83	0.93	0.83	-0.28	0.9	0.98	0.99	0.23	0.97
Non Currrent Assets Other	0.02	-0.44	0.21	0.06	0.05	0.07	0.19	-0.03	0.4	0.24	-0.12	0.04		-0.21	0.24	-0.04	0.04	-0.22	0.28	0.22	0.49	-0.05	0.13	0.01	-0.28	-0.08
Cash And Short Term Investments	0.9	0.69	0.79	0.88	0.88	0.91	0.78	-0.64	0.37	0.73	0.96	0.89	-0.21		0.63	0.95	0.7	0.82	0.71	0.56	-0.54	0.87	0.84	0.92	0.55	0.96
Net Receivables	0.9	0.26	0.93	0.84	0.88	0.87	0.95	-0.59	0.92	0.97	0.74	0.88	0.24	0.63		0.79	0.81	0.68	0.98	0.91	0.09	0.85	0.88	0.88	0.04	0.77
Common Stock Total Equity	0.97	0.48	0.87	0.88	0.98	0.99	0.9	-0.8	0.6	0.88	0.99	0.98	-0.04	0.95	0.79		0.82	0.82	0.86	0.74	-0.36	0.86	0.97	0.98	0.3	1.0
Common Stock Shares Outstanding	0.85	0.32	0.79	0.72	0.86	0.84	0.83	-0.74	0.72	0.85	0.81	0.86	0.04	0.7	0.81	0.82		0.69	0.83	0.79	-0.14	0.73	0.86	0.84	0.04	0.82
Non Current Liabilities Total	0.84	0.66	0.72	0.73	0.8	0.81	0.76	-0.46	0.48	0.7	0.8	0.83	-0.22	0.82	0.68	0.82	0.69		0.73	0.65	-0.49	0.85	0.75	0.84	0.28	0.82
Inventory	0.93	0.28	0.95	0.86	0.93	0.93	0.98	-0.65	0.88	0.99	0.81	0.93	0.28	0.71	0.98	0.86	0.83	0.73		0.89	0.02	0.86	0.94	0.92	0.08	0.84
Other Current Assets	0.83	0.13	0.79	0.69	0.84	0.81	0.89	-0.65	0.89	0.91	0.7	0.83	0.22	0.56	0.91	0.74	0.79	0.65	0.89		0.0	0.74	0.84	0.81	-0.13	0.73
Other Stockholder Equity	-0.28	-0.64	-0.08	-0.27	-0.25	-0.27	-0.06	0.11	0.29	-0.01	-0.41	-0.28	0.49	-0.54	0.09	-0.36	-0.14	-0.49	0.02	0.0		-0.34	-0.16	-0.3	-0.54	-0.38
Total Liab	0.94	0.7	0.92	0.97	0.88	0.9	0.89	-0.44	0.63	0.84	0.84	0.9	-0.05	0.87	0.85	0.86	0.73	0.85	0.86	0.74	-0.34		0.82	0.94	0.5	0.86
Property Plant And Equipment Gross	0.97	0.29	0.89	0.84	0.99	0.98	0.95	-0.84	0.76	0.96	0.94	0.98	0.13	0.84	0.88	0.97	0.86	0.75	0.94	0.84	-0.16	0.82		0.96	0.11	0.96
Total Current Assets	1.0	0.53	0.94	0.94	0.98	0.99	0.95	-0.7	0.69	0.93	0.95	0.99	0.01	0.92	0.88	0.98	0.84	0.84	0.92	0.81	-0.3	0.94	0.96		0.33	0.97
Short Term Debt	0.28	0.85	0.31	0.56	0.18	0.25	0.13	0.18	-0.28	0.03	0.32	0.23	-0.28	0.55	0.04	0.3	0.04	0.28	0.08	-0.13	-0.54	0.5	0.11	0.33		0.32
Common Stock	0.97	0.5	0.86	0.87	0.97	0.98	0.89	-0.8	0.57	0.87	1.0	0.97	-0.08	0.96	0.77	1.0	0.82	0.82	0.84	0.73	-0.38	0.86	0.96	0.97	0.32

Click cells to compare fundamentals

Cochlear Account Relationship Matchups

Cochlear balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	2.4B	2.5B	2.6B	2.7B	3.2B	3.3B
Short Long Term Debt Total	264.3M	253.9M	201.8M	243.7M	280.3M	165.5M
Other Current Liab	112M	146.6M	189.3M	202.4M	232.8M	244.4M
Total Current Liabilities	402.5M	527.6M	578M	631.5M	726.2M	762.5M
Total Stockholder Equity	1.7B	1.7B	1.7B	1.8B	2.1B	2.2B
Property Plant And Equipment Net	428.5M	439.2M	447.2M	517.2M	594.8M	624.5M
Current Deferred Revenue	42.8M	54.7M	61.6M	66.7M	76.7M	80.5M
Net Debt	(345.3M)	(375.4M)	(353.7M)	(269.9M)	(242.9M)	(230.8M)
Retained Earnings	355.1M	455.3M	555.4M	667.9M	768.1M	806.5M
Accounts Payable	202.9M	232.4M	270.4M	303.2M	348.7M	366.1M
Cash	609.6M	629.3M	555.5M	513.6M	590.6M	620.2M
Non Current Assets Total	1.2B	1.1B	1.2B	1.3B	1.5B	1.6B
Non Currrent Assets Other	(267.3M)	(257.1M)	(256.1M)	102.7M	92.4M	97.1M
Cash And Short Term Investments	609.6M	629.3M	555.5M	513.6M	590.6M	620.2M
Net Receivables	296.3M	390.4M	457.5M	502M	577.3M	606.2M
Common Stock Shares Outstanding	65.7M	65.8M	65.9M	65.7M	75.6M	62.0M
Liabilities And Stockholders Equity	2.4B	2.5B	2.6B	2.7B	3.2B	3.3B
Non Current Liabilities Total	334M	251.8M	241.9M	273.1M	314.1M	329.8M
Inventory	216.1M	270.2M	311.5M	391.6M	450.3M	472.9M
Other Current Assets	38.8M	37.1M	37M	44.9M	51.6M	54.2M
Other Stockholder Equity	(15.3M)	(1.4B)	(1.6B)	(1.0)	(0.9)	(0.94)
Total Liab	736.5M	779.4M	819.9M	904.6M	1.0B	1.1B
Property Plant And Equipment Gross	636.5M	672.8M	710.6M	811.8M	933.6M	980.2M
Total Current Assets	1.2B	1.3B	1.4B	1.5B	1.7B	1.8B
Accumulated Other Comprehensive Income	57.9M	(46.2M)	(56.9M)	(31.6M)	(28.4M)	(27.0M)
Short Term Debt	31.9M	78.7M	39.2M	41.6M	47.8M	55.6M
Other Liab	71.3M	101.6M	76.6M	79.3M	91.2M	48.0M
Other Assets	212.3M	203.4M	220.3M	1.0	1.15	1.09
Property Plant Equipment	438.8M	428.5M	439.2M	447.2M	514.3M	540.0M
Intangible Assets	385.5M	392.5M	444.1M	193.3M	222.3M	143.5M
Good Will	267.3M	257.1M	256.1M	257.7M	296.4M	219.4M
Short Term Investments	27.3M	68.8M	90.8M	102.7M	118.1M	105.7M
Net Tangible Assets	1.0B	1.4B	1.3B	1.3B	1.5B	840.2M
Long Term Debt Total	285.4M	232.4M	175.2M	162.6M	187.0M	206.4M
Long Term Investments	199.5M	119.1M	97.3M	83.4M	95.9M	83.9M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Cochlear Stock Analysis

When running Cochlear's price analysis, check to measure Cochlear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cochlear is operating at the current time. Most of Cochlear's value examination focuses on studying past and present price action to predict the probability of Cochlear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cochlear's price. Additionally, you may evaluate how the addition of Cochlear to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC